Vitamin K for Vascular Calcification in Kidney Patients: Still Alive and Kicking, but Still a Lot to Learn
Authors:
- Ioannis Eleftherios NeofytouINIoannis Eleftherios Neofytou
- Aikaterini StamouASAikaterini Stamou
- Antonia DemopoulosADAntonia Demopoulos
- Stefanos RoumeliotisStefanos Roumeliotis
- Pantelis ZebekakisPZPantelis Zebekakis
- Vassilios LiakopoulosVassilios Liakopoulos
- Eleni StamellouESEleni Stamellou
- Evangelia DounousiEDEvangelia Dounousi
Open Access
Abstract
Patients with chronic kidney disease (CKD) suffer disproportionately from a high burden of cardiovascular disease, which, despite recent scientific advances, remains partly understood. Vascular calcification (VC) is the result of an ongoing process of misplaced calcium in the inner and medial layers of the arteries, which has emerged as a critical contributor to cardiovascular events in CKD. Beyond its established role in blood clotting and bone health, vitamin K appears crucial in regulating VC via vitamin K-dependent proteins (VKDPs). Among these, the matrix Gla protein (MGP) serves as both a potent inhibitor of VC and a valuable biomarker (in its inactive form) for reflecting circulating vitamin K levels. CKD patients, especially in advanced stages, often present with vitamin K deficiency due to dietary restrictions, medications, and impaired intestinal absorption in the uremic environment. Epidemiological studies confirm a strong association between vitamin K levels, inactive MGP, and increased CVD risk across CKD stages. Based on the promising results of pre-clinical data, an increasing number of clinical trials have investigated the potential benefits of vitamin K supplementation to prevent, delay, or even reverse VC, but the results have remained inconsistent.Keywords
This publication has 150 references indexed in Scilit:
- Calciprotein Particle Synthesis Strategy Determines In Vitro Calcification PotentialCalcified Tissue International, 2022
- Letter to the Editor regarding “Six months vitamin K treatment does not affect systemic arterial calcification or bone mineral density in diabetes mellitus 2”European Journal of Nutrition, 2021
- Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal DiseaseJournal of Bone and Mineral Research, 2018
- Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney DiseaseJAMA Cardiology, 2017
- Polymorphism in the human matrix Gla protein gene is associated with the progression of vascular calcification in maintenance hemodialysis patientsClinical and Experimental Nephrology, 2013
- Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis studyJournal of Bone and Mineral Research, 2012
- Role of vitamin K and vitamin K-dependent proteins in vascular calcificationClinical Research in Cardiology, 2001
- Des-γ-carboxy (abnormal) prothrombin and hepatocellular carcinoma: A critical reviewHepatology, 1993
- Plasma concentrations of vitamin K1 and PIVKA-II in bottle-fed and breast-fed infants with and without vitamin K prophylaxis at birthEuropean Journal of Pediatrics, 1988
- Mechanism of Cephalosporin‐induced Hypoprothrombinemia: Relation to Cephalosporin Side Chain, Vitamin K Metabolism, and Vitamin K StatusThe Journal of Clinical Pharmacology, 1988